SCHEMBL3657705

SCHEMBL3657705

CCCCCCCc1cc(=O)c2ccc(O)cc2o1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.78
LOXL2 Q9Y4K0 1/20 0.59
PPARG P37231 1/20 0.57
ALDH1A1 P00352 2/20 0.56
GAA P10253 1/20 0.56
ERAP1 Q9NZ08 1/20 0.56
HSD17B3 P37058 3/20 0.52
STS P08842 1/20 0.52
AKR1B1 P15121 2/20 0.50
KDM4E B2RXH2 1/20 0.48
MPO P05164 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP19A1 P11511 1/20 0.48
HPGD P15428 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
QPCT Q16769 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658889 1.00 ALOX15 (0.78) ALOX15LOXL2PPARGALDH1A1GAA
SCHEMBL3663082 1.00 ALOX15 (0.78) ALOX15LOXL2PPARGALDH1A1GAA
SCHEMBL3658287 0.99 ALOX15 (0.80) ALOX15LOXL2PPARGALDH1A1GAA
SCHEMBL3661429 0.94 ALOX15 (0.72) ALOX15LOXL2PPARGALDH1A1GAA
SCHEMBL7573085 0.89 ALOX15 (0.97) ALOX15LOXL2PPARGALDH1A1GAA
SCHEMBL7673826 0.83 ALOX15 (0.92) ALOX15LOXL2PPARGALDH1A1GAA
SCHEMBL9363716 0.82 LOXL2 (0.69) ALOX15LOXL2ALDH1A1HSD17B3AKR1B1
SCHEMBL3660146 0.81 ALOX15 (0.66) ALOX15PPARGSTSCYP3A4MAOB
SCHEMBL21166318 0.81 ALOX15 (0.66) ALOX15PPARGSTSCYP3A4MAOB
SCHEMBL3654554 0.81 ALOX15 (0.66) ALOX15PPARGSTSCYP3A4MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11642288-B2 Skin external composition KAO CORPORATION (JP) 2023-05-09 US disclosed
CN-111491604-B Method for producing composition containing hardly water-soluble aromatic compound 花王株式会社 2023-03-21 CN disclosed
EP-4104862-A1 SKIN COMPOSITION FOR EXTERNAL USE Kao Corporation (JP) 2022-12-21 EP disclosed
EP-3733155-B1 METHOD FOR MANUFACTURING COMPOSITION THAT INCLUDES POORLY WATER-SOLUBLE AROMATIC COMPOUND KAO CORP (JP) 2022-11-23 EP disclosed
US-20220287923-A1 SKIN EXTERNAL COMPOSITION KAO CORPORATION (JP) 2022-09-15 US disclosed
US-11419797-B2 Method for producing composition containing hardly water-soluble aromatic compound KAO CORPORATION (JP) 2022-08-23 US disclosed
EP-4032524-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND Kao Corporation (JP) 2022-07-27 EP disclosed
CN-113950336-A Composition for external application to skin 花王株式会社 2022-01-18 CN disclosed
US-20210059909-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND KAO CORPORATION (JP) 2021-03-04 US disclosed
EP-3733155-A1 METHOD FOR MANUFACTURING COMPOSITION THAT INCLUDES POORLY WATER-SOLUBLE AROMATIC COMPOUND Kao Corporation (JP) 2020-11-04 EP disclosed
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC ALOX15 3447/4885LOXL2 4219/4885PPARG 1178/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR ALOX15 670/4885LOXL2 167/4885PPARG 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.